Messages in brief

News

Review of generic approvals with regard to potentially falsified bioequivalence studies.

Safety warnings | messages in brief | 12/12/2014

An inspection by the French Medicines Agency (ANSM) of the research service provider GVK Biosciences in Hyderabad (India) has revealed serious…

Review of generic approvals with regard to potentially falsified bioequivalence studies. Read more
News

Falsified bioequivalence studies could lead to approval suspensions for individual generic drugs

Safety warnings | messages in brief | 06/12/2014

An inspection by the French Medicines Agency (ANSM) of the research service provider GVK Biosciences in Hyderabad (India) has revealed serious…

Falsified bioequivalence studies could lead to approval suspensions for individual generic drugs Read more
News

Deactivation of e-mail addresses "spc@ages.at" and "mrp-spc@ages.at for human medicines

messages in brief | 03/12/2014
As previously announced, the following e-mail addresses spc@ages.at and mrp-spc@ages.at are deactivated on 31.01.2014.

Austrian "Summaries of Product…
Deactivation of e-mail addresses "spc@ages.at" and "mrp-spc@ages.at for human medicines Read more
News

Italy: suspension of 2 batches of Fluad, Austria not affected

Safety warnings | messages in brief | 28/11/2014

Austria has been informed by the Italian Medicines Agency (AIFA) of a precautionary suspension of two batches (142701 and 143301) of the influenza…

Italy: suspension of 2 batches of Fluad, Austria not affected Read more
News

Use of valproate during pregnancy

Safety warnings | messages in brief | 16/10/2014

The Federal Office provides information on recommendations of the Committee for Risk Assessment and Pharmacovigilance (PRAC) within the framework of…

Use of valproate during pregnancy Read more
News

Telephone inquiries / calls on behalf of AGES - Update

messages in brief | 16/10/2014

Status 06.09.2014:

The BASG / AGES Medical Market Surveillance became aware that dubious persons were contacting by telephone in the name of AGES…

Telephone inquiries / calls on behalf of AGES - Update Read more
News

Instructions for the correct use of auto-injectors with the active ingredient adrenaline (epinephrine) for emergency treatment

Safety warnings | messages in brief | 25/09/2014

Auto-injectors containing adrenaline are used for emergency treatment of anaphylactic shock or allergic reaction (e.g. to insect stings or bites, food…

Instructions for the correct use of auto-injectors with the active ingredient adrenaline (epinephrine) for emergency treatment Read more
News

Current information on manipulated drugs

Safety warnings | messages in brief | 17/09/2014

Situation EU: In addition to individual cases of manipulated, parallel distributed Italian Herceptin, manipulated, parallel distributed MabThera of…

Current information on manipulated drugs Read more
News

"Operation Vigorali": Europe-wide trafficking of counterfeit medicines solved

messages in brief | 01/09/2014
The Federal Criminal Police Office, in cooperation with AGES, today struck a decisive blow against an international drug counterfeiting ring.
"Operation Vigorali": Europe-wide trafficking of counterfeit medicines solved Read more
Email

Further inquiry note